Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Valeant Pharmaceuticals International, Inc. Investors

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/9/2026

1. USO
2. META
3. SPY
4. MSFT
5. MU
6. COST
7. IONS
8. SKHY
9. ORCL
10. RMR

Go back to Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Valeant Pharmaceuticals International, Inc. Investors

BTIG Thinks Valeant (VRX) Should Just Severe Ties with Philidor; PT Cut to $175

October 26, 2015 2:53 PM EDT

BTIG is cutting its price target on Valeant Pharma (NYSE: VRX) from $210 down to $175, but maintaining a Buy rating following this morning's conference call.

Analyst Timothy Chiang commented, More details were provided this morning on Valeants call highlighting its relationship with Philidor,... More